Published in FEMS Immunol Med Microbiol on March 10, 2010
Gut adhesive Bacillus subtilis spores as a platform for mucosal delivery of antigens. Infect Immun (2014) 0.80
Bacillus subtilis spores as vaccine adjuvants: further insights into the mechanisms of action. PLoS One (2014) 0.78
Immunogenicity and in vitro and in vivo protective effects of antibodies targeting a recombinant form of the Streptococcus mutans P1 surface protein. Infect Immun (2014) 0.75
Genome sequence of Streptococcus mutans UA159, a cariogenic dental pathogen. Proc Natl Acad Sci U S A (2002) 8.25
Oral microbial communities in sickness and in health. Trends Microbiol (2005) 3.40
A forespore checkpoint for mother cell gene expression during development in B. subtilis. Cell (1990) 3.28
Overview of bacterial expression systems for heterologous protein production: from molecular and biochemical fundamentals to commercial systems. Appl Microbiol Biotechnol (2006) 3.23
Construction and characterization of isogenic mutants of Streptococcus mutans deficient in major surface protein antigen P1 (I/II). Infect Immun (1989) 3.06
Characterisation of antigens extracted from cells and culture fluids of Streptococcus mutans serotype c. Arch Oral Biol (1978) 3.03
Streptococcus adherence and colonization. Microbiol Mol Biol Rev (2009) 2.83
Immunization with purified protein antigens from Streptococcus mutans against dental caries in rhesus monkeys. Infect Immun (1981) 2.72
Protein sorting to the cell wall envelope of Gram-positive bacteria. Biochim Biophys Acta (2004) 2.42
Surface hydrophobicity, adherence, and aggregation of cell surface protein antigen mutants of Streptococcus mutans serotype c. Infect Immun (1990) 1.95
Local passive immunization by monoclonal antibodies against streptococcal antigen I/II in the prevention of dental caries. Infect Immun (1985) 1.92
Characterization of a salivary agglutinin reacting with a serotype c strain of Streptococcus mutans. Eur J Biochem (1983) 1.92
Mucosal immunization with a bacterial protein antigen genetically coupled to cholera toxin A2/B subunits. J Immunol (1995) 1.89
Molecular cloning and expression of a Streptococcus mutans major surface protein antigen, P1 (I/II), in Escherichia coli. Infect Immun (1988) 1.88
Differentiation of salivary agglutinin-mediated adherence and aggregation of mutans streptococci by use of monoclonal antibodies against the major surface adhesin P1. Infect Immun (1992) 1.88
Adherent interactions which may affect microbial ecology in the mouth. J Dent Res (1984) 1.87
Identification of a salivary agglutinin-binding domain within cell surface adhesin P1 of Streptococcus mutans. Infect Immun (1993) 1.77
Identification of an endogenous membrane anchor-cleaving enzyme for group A streptococcal M protein. Its implication for the attachment of surface proteins in gram-positive bacteria. J Exp Med (1989) 1.77
Use of monoclonal antibodies in local passive immunization to prevent colonization of human teeth by Streptococcus mutans. Infect Immun (1987) 1.70
Functions of cell surface-anchored antigen I/II family and Hsa polypeptides in interactions of Streptococcus gordonii with host receptors. Infect Immun (2005) 1.54
Biological control in greenhouse systems. Annu Rev Phytopathol (2001) 1.52
Bacillus subtilis and its relatives: molecular biological and industrial workhorses. Trends Biotechnol (1992) 1.47
Strains of Streptococcus mutans and Streptococcus sobrinus attach to different pellicle receptors. Infect Immun (1986) 1.46
Virulence of a spaP mutant of Streptococcus mutans in a gnotobiotic rat model. Infect Immun (1999) 1.40
A protein fragment of streptococcal cell surface antigen I/II which prevents adhesion of Streptococcus mutans. Infect Immun (1993) 1.30
Saliva-mediated aggregation of Enterococcus faecalis transformed with a Streptococcus sanguis gene encoding the SSP-5 surface antigen. Infect Immun (1989) 1.29
Elongated fibrillar structure of a streptococcal adhesin assembled by the high-affinity association of alpha- and PPII-helices. Proc Natl Acad Sci U S A (2010) 1.27
Immunogenicity and protective effect against oral colonization by Streptococcus mutans of synthetic peptides of a streptococcal surface protein antigen. J Immunol (1991) 1.26
The FtsH protein accumulates at the septum of Bacillus subtilis during cell division and sporulation. J Bacteriol (2000) 1.24
Restriction fragment length polymorphisms and sequence variation within the spaP gene of Streptococcus mutans serotype c isolates. Infect Immun (1991) 1.19
Role of the C terminus in antigen P1 surface localization in Streptococcus mutans and two related cocci. J Bacteriol (1996) 1.19
Deletion of the central proline-rich repeat domain results in altered antigenicity and lack of surface expression of the Streptococcus mutans P1 adhesin molecule. Infect Immun (1998) 1.17
T-cell, adhesion, and B-cell epitopes of the cell surface Streptococcus mutans protein antigen I/II. Infect Immun (1995) 1.16
Saliva-binding region of Streptococcus mutans surface protein antigen. Infect Immun (1993) 1.15
Identification and characterization of an antigen I/II family protein produced by group A Streptococcus. Infect Immun (2006) 1.14
A vaccine against dental caries: an overview. BioDrugs (2001) 1.12
Production of recombinant proteins in Bacillus subtilis. Adv Appl Microbiol (2007) 1.12
Dental caries vaccine. Indian J Dent Res (2009) 1.06
Comparison of an adherence domain and a structural region of Streptococcus mutans antigen I/II in protective immunity against dental caries in rats after intranasal immunization. Infect Immun (1998) 1.04
Enhanced immunogenicity of a genetic chimeric protein consisting of two virulence antigens of Streptococcus mutans and protection against infection. Infect Immun (2002) 1.00
Identification of antigenic epitopes in an alanine-rich repeating region of a surface protein antigen of Streptococcus mutants. Infect Immun (1993) 1.00
Oral immunization with the saliva-binding region of Streptococcus mutans AgI/II genetically coupled to the cholera toxin B subunit elicits T-helper-cell responses in gut-associated lymphoid tissues. Infect Immun (1997) 1.00
Characterization of epitopes recognized by anti-Streptococcus mutans P1 monoclonal antibodies. FEMS Immunol Med Microbiol (2007) 0.97
Expression vectors for the rapid purification of recombinant proteins in Bacillus subtilis. Curr Microbiol (2007) 0.96
The Bacillus secretion stress response is an indicator for alpha-amylase production levels. Lett Appl Microbiol (2004) 0.94
Secretion of functional human interleukin-3 from Bacillus subtilis. J Biotechnol (2005) 0.94
Contribution of the alanine-rich region of Streptococcus mutans P1 to antigenicity, surface expression, and interaction with the proline-rich repeat domain. Infect Immun (2004) 0.92
Bacillus subtilis as a tool for vaccine development: from antigen factories to delivery vectors. An Acad Bras Cienc (2005) 0.91
Bacteria-agglutinating characteristics of secretory IgA and a salivary agglutinin. Adv Exp Med Biol (1987) 0.89
Peptide mapping of a novel discontinuous epitope of the major surface adhesin from Streptococcus mutans. J Biol Chem (2004) 0.89
Evaluation of different promoter sequences and antigen sorting signals on the immunogenicity of Bacillus subtilis vaccine vehicles. Vaccine (2007) 0.88
Engineering and production of streptokinase in a Bacillus subtilis expression-secretion system. Appl Environ Microbiol (1994) 0.87
Beneficial immunomodulation by Streptococcus mutans anti-P1 monoclonal antibodies is Fc independent and correlates with increased exposure of a relevant target epitope. J Immunol (2009) 0.86
Secretory immunity following mutans streptococcal infection or immunization. Curr Top Microbiol Immunol (2008) 0.86
Characterization of the Streptococcus mutans P1 epitope recognized by immunomodulatory monoclonal antibody 6-11A. Infect Immun (2004) 0.83
Role of peptide antigen for induction of inhibitory antibodies to Streptococcus mutans in human oral cavity. Clin Exp Immunol (2004) 0.81
Stable episomal expression system under control of a stress inducible promoter enhances the immunogenicity of Bacillus subtilis as a vector for antigen delivery. Vaccine (2005) 0.81
Immunogenicity of peptides coupled with multiple T-cell epitopes of a surface protein antigen of Streptococcus mutans. Immunology (1996) 0.80
Identification of Streptococcus mutans PAc peptide motif binding with human MHC class II molecules (DRB1*0802, *1101, *1401 and *1405). Immunology (1998) 0.78
Molecular interactions of alanine-rich and proline-rich regions of cell surface protein antigen c in Streptococcus mutans. Oral Microbiol Immunol (2008) 0.78
A unique serine-rich repeat protein (Srr-2) and novel surface antigen (epsilon) associated with a virulent lineage of serotype III Streptococcus agalactiae. Microbiology (2006) 1.92
JunD-mediated repression of GADD45α and γ regulates escape from cell death in prostate cancer. Cell Cycle (2011) 1.63
Streptococcal viability and diminished stress tolerance in mutants lacking the signal recognition particle pathway or YidC2. Proc Natl Acad Sci U S A (2005) 1.50
Elongated fibrillar structure of a streptococcal adhesin assembled by the high-affinity association of alpha- and PPII-helices. Proc Natl Acad Sci U S A (2010) 1.27
Characteristics of biofilm formation by Streptococcus mutans in the presence of saliva. Infect Immun (2008) 1.19
Membrane composition changes and physiological adaptation by Streptococcus mutans signal recognition particle pathway mutants. J Bacteriol (2006) 1.14
Characterization of group B streptococcal glyceraldehyde-3-phosphate dehydrogenase: surface localization, enzymatic activity, and protein-protein interactions. Can J Microbiol (2003) 1.14
Consequences of a sortase A mutation in Streptococcus gordonii. Microbiology (2007) 1.13
Commentaries on viewpoint: A paradigm shift for local blood flow regulation. J Appl Physiol (1985) (2014) 1.07
Independent gene duplications of the YidC/Oxa/Alb3 family enabled a specialized cotranslational function. Proc Natl Acad Sci U S A (2009) 1.04
CD8+ T cell adjuvant effects of Salmonella FliCd flagellin in live vaccine vectors or as purified protein. Vaccine (2009) 1.00
Characterization of epitopes recognized by anti-Streptococcus mutans P1 monoclonal antibodies. FEMS Immunol Med Microbiol (2007) 0.97
Crystal structure of the C-terminal region of Streptococcus mutans antigen I/II and characterization of salivary agglutinin adherence domains. J Biol Chem (2011) 0.96
A whole cell BIAcore assay to evaluate P1-mediated adherence of Streptococcus mutans to human salivary agglutinin and inhibition by specific antibodies. J Microbiol Methods (2005) 0.95
Functional overlap but lack of complete cross-complementation of Streptococcus mutans and Escherichia coli YidC orthologs. J Bacteriol (2008) 0.95
Functional and immunological characterization of a natural polymorphic variant of a heat-labile toxin (LT-I) produced by enterotoxigenic Escherichia coli (ETEC). FEMS Immunol Med Microbiol (2008) 0.95
An ffh mutant of Streptococcus mutans is viable and able to physiologically adapt to low pH in continuous culture. FEMS Microbiol Lett (2004) 0.94
Solubilization of cellular membrane proteins from Streptococcus mutans for two-dimensional gel electrophoresis. Electrophoresis (2005) 0.93
Paracoccidioides brasiliensis vaccine formulations based on the gp43-derived P10 sequence and the Salmonella enterica FliC flagellin. Infect Immun (2009) 0.93
Requirements for surface expression and function of adhesin P1 from Streptococcus mutans. Infect Immun (2008) 0.92
Contribution of the alanine-rich region of Streptococcus mutans P1 to antigenicity, surface expression, and interaction with the proline-rich repeat domain. Infect Immun (2004) 0.92
Bacillus subtilis as a tool for vaccine development: from antigen factories to delivery vectors. An Acad Bras Cienc (2005) 0.91
The molybdate-binding protein (ModA) of the plant pathogen Xanthomonas axonopodis pv. citri. Protein Expr Purif (2006) 0.91
Redirecting the humoral immune response against Streptococcus mutans antigen P1 with monoclonal antibodies. Infect Immun (2004) 0.89
Preserved flow-mediated dilation but delayed time-to-peak diameter in individuals with metabolic syndrome. Clin Physiol Funct Imaging (2013) 0.88
Evaluation of different promoter sequences and antigen sorting signals on the immunogenicity of Bacillus subtilis vaccine vehicles. Vaccine (2007) 0.88
Refolded dengue virus type 2 NS1 protein expressed in Escherichia coli preserves structural and immunological properties of the native protein. J Virol Methods (2010) 0.88
Functional diversity of heat-labile toxins (LT) produced by enterotoxigenic Escherichia coli: differential enzymatic and immunological activities of LT1 (hLT) AND LT4 (pLT). J Biol Chem (2010) 0.87
A therapeutic anti-Streptococcus mutans monoclonal antibody used in human passive protection trials influences the adaptive immune response. Vaccine (2011) 0.87
Targeting the non-structural protein 1 from dengue virus to a dendritic cell population confers protective immunity to lethal virus challenge. PLoS Negl Trop Dis (2013) 0.86
Further characterization of immunomodulation by a monoclonal antibody against Streptococcus mutans antigen P1. Infect Immun (2004) 0.86
Beneficial immunomodulation by Streptococcus mutans anti-P1 monoclonal antibodies is Fc independent and correlates with increased exposure of a relevant target epitope. J Immunol (2009) 0.86
Distinctive immunomodulatory and inflammatory properties of the Escherichia coli type II heat-labile enterotoxin LT-IIa and its B pentamer following intradermal administration. Clin Vaccine Immunol (2011) 0.85
YidC1 and YidC2 are functionally distinct proteins involved in protein secretion, biofilm formation and cariogenicity of Streptococcus mutans. Microbiology (2012) 0.85
Binding forces of Streptococcus mutans P1 adhesin. ACS Nano (2015) 0.84
Water intake accelerates post-exercise cardiac vagal reactivation in humans. Eur J Appl Physiol (2007) 0.84
Aberrant methylation of the MSH3 promoter and distal enhancer in esophageal cancer patients exposed to first-hand tobacco smoke. J Cancer Res Clin Oncol (2014) 0.84
Structural and physiological analyses of the alkanesulphonate-binding protein (SsuA) of the citrus pathogen Xanthomonas citri. PLoS One (2013) 0.83
Cytotoxic T cell adjuvant effects of three Salmonella enterica flagellins. Braz J Microbiol (2008) 0.83
Immune responses and therapeutic antitumor effects of an experimental DNA vaccine encoding human papillomavirus type 16 oncoproteins genetically fused to herpesvirus glycoprotein D. Clin Vaccine Immunol (2010) 0.83
Characterization of the Streptococcus mutans P1 epitope recognized by immunomodulatory monoclonal antibody 6-11A. Infect Immun (2004) 0.83
Roles of nitric oxide and prostaglandins in the hyperemic response to a maximal metabolic stimulus: redundancy prevails. Eur J Appl Physiol (2012) 0.82
Basis of beneficial immunomodulation by monoclonal antibodies against Streptococcus mutans adhesin P1. FEMS Immunol Med Microbiol (2007) 0.82
Salmonella enterica serovar Typhimurium vaccine strains expressing a nontoxic Shiga-like toxin 2 derivative induce partial protective immunity to the toxin expressed by enterohemorrhagic Escherichia coli. Clin Vaccine Immunol (2010) 0.82
An intramolecular interaction involving the N terminus of a streptococcal adhesin affects its conformation and adhesive function. J Biol Chem (2013) 0.82
Bacillus subtilis endospores at high purity and recovery yields: optimization of growth conditions and purification method. Curr Microbiol (2012) 0.82
Site-directed gene replacement of the phytopathogen Xanthomonas axonopodis pv. citri. J Microbiol Methods (2005) 0.81
Stable episomal expression system under control of a stress inducible promoter enhances the immunogenicity of Bacillus subtilis as a vector for antigen delivery. Vaccine (2005) 0.81
Aerobic exercise acutely prevents the endothelial dysfunction induced by mental stress among subjects with metabolic syndrome: the role of shear rate. Am J Physiol Heart Circ Physiol (2014) 0.80
Effect of the 894G>T polymorphism of the endothelial nitric oxide synthase on vascular reactivity following maximal dynamic exercise. J Hypertens (2010) 0.80
Gut adhesive Bacillus subtilis spores as a platform for mucosal delivery of antigens. Infect Immun (2014) 0.80
Isolation and solubilization of cellular membrane proteins from bacteria. Methods Mol Biol (2008) 0.80
YlxM is a newly identified accessory protein that influences the function of signal recognition particle pathway components in Streptococcus mutans. J Bacteriol (2014) 0.79
Effect of Ischemic Preconditioning on Endurance Performance Does Not Surpass Placebo. Med Sci Sports Exerc (2017) 0.78
Enhanced therapeutic effects conferred by an experimental DNA vaccine targeting human papillomavirus-induced tumors. Hum Gene Ther (2013) 0.78
Bicistronic DNA vaccines simultaneously encoding HIV, HSV and HPV antigens promote CD8⁺ T cell responses and protective immunity. PLoS One (2013) 0.77
Cardiac vagal withdrawal and reactivation during repeated rest-exercise transitions. Eur J Appl Physiol (2010) 0.77
Ischemic Preconditioning and Repeated Sprint Swimming: A Placebo and Nocebo Study. Med Sci Sports Exerc (2016) 0.77
Sex differences in blood pressure responses to mental stress are abolished after a single bout of exercise: underlying hemodynamic mechanisms. J Physiol Sci (2014) 0.77
Ischemic exercise hyperemia in the human forearm: reproducibility and roles of adenosine and nitric oxide. Eur J Appl Physiol (2011) 0.76
Diet and exercise training reduce blood pressure and improve autonomic modulation in women with prehypertension. Eur J Appl Physiol (2012) 0.76
Distribution and biological role of the oligopeptide-binding protein (OppA) in Xanthomonas species. Genet Mol Biol (2010) 0.75
Ascent to altitude: an integrated cerebrovascular, ventilatory and acid-base response. J Physiol (2010) 0.75
Effect of Intermittent Hypoxic Training Followed by Intermittent Hypoxic Exposure on Aerobic Capacity of Long Distance Runners. J Strength Cond Res (2016) 0.75
Intracellular polyamine pools, oligopeptide-binding protein A expression, and resistance to aminoglycosides in Escherichia coli. Mem Inst Oswaldo Cruz (2006) 0.75
Oligopeptide uptake and aminoglycoside resistance in Escherichia coli K12. FEMS Microbiol Lett (2007) 0.75
Antibody-inducing properties of a prototype bivalent herpes simplex virus/enterotoxigenic Escherichia coli DNA vaccine. FEMS Immunol Med Microbiol (2003) 0.75